Eldorado Gold Corporation (TSX:ELD)

Verve Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	5,883	4,365	3,504	2,082	2,163	2,939
Market Cap Growth	37.98%	24.57%	68.28%	-3.75%	-26.41%	77.84%
Enterprise Value	5,939	4,371	3,558	2,367	2,287	3,074
Last Close Price	29.00	21.38	17.20	11.29	11.86	16.87
PE Ratio	10.43	10.49	25.36	-	-	18.49
Forward PE	7.91	8.66	18.32	17.87	14.37	13.28
PS Ratio	2.74	2.29	2.63	1.76	1.82	2.25
PB Ratio	1.06	0.78	0.76	0.48	0.47	0.63
P/TBV Ratio	1.08	0.80	0.77	0.49	0.49	0.65
P/FCF Ratio	-	195.14	-	-	21.29	8.21
P/OCF Ratio	-	4.70	6.92	7.29	4.72	4.91
PEG Ratio	-	1.89	1.89	1.89	1.89	1.89
EV/Sales Ratio	2.77	2.30	2.67	2.01	1.92	2.35
EV/EBITDA Ratio	5.08	4.53	6.17	5.80	4.43	4.72
EV/EBIT Ratio	7.45	7.31	15.72	27.99	8.49	8.14
EV/FCF Ratio	-311.99	195.42	-	-	22.51	8.58
Debt / Equity Ratio	0.29	0.24	0.19	0.16	0.14	0.14
Debt / EBITDA Ratio	1.37	1.38	1.48	1.66	1.23	1.02
Debt / FCF Ratio	-	59.84	-	-	6.38	1.88
Asset Turnover	0.27	0.24	0.21	0.19	0.19	0.21
Inventory Turnover	2.29	2.24	2.28	2.62	2.72	2.78
Quick Ratio	2.46	2.68	2.35	1.81	2.58	2.16
Current Ratio	3.23	3.60	3.39	3.00	3.52	2.88
Return on Equity (ROE)	10.91%	8.13%	3.15%	-1.44%	0.53%	3.46%
Return on Assets (ROA)	6.31%	4.80%	2.27%	0.83%	2.70%	3.87%
Return on Capital (ROIC)	7.54%	5.78%	2.72%	0.99%	3.18%	4.52%
Return on Capital Employed (ROCE)	10.10%	7.70%	3.60%	1.50%	4.50%	6.30%
Earnings Yield	9.51%	9.53%	3.94%	-23.00%	-7.96%	5.41%
FCF Yield	-0.32%	0.51%	-1.11%	-5.13%	4.70%	12.19%
Buyback Yield / Dilution	-1.20%	-5.23%	-6.48%	-0.92%	-3.73%	-8.48%
Total Shareholder Return	-	-5.23%	-6.48%	-0.92%	-3.73%	-8.48%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.